British Journal of Dermatology

Cover image for Vol. 175 Issue 2

Editor: Alex Anstey, Bangor, UK

Impact Factor: 4.317

ISI Journal Citation Reports © Ranking: 2015: 5/61 (Dermatology)

Online ISSN: 1365-2133

Associated Title(s): Clinical and Experimental Dermatology

BJD Virtual Issues


Welcome to the BJD Virtual Issues page

List of issues


Issue 5, November 2012: Dermatologic Surgery Articles
read online

Issue 4, August 2012: Top Cited Melanoma Articles
read online

Issue 3, April 2011: Top Cited Asian Publications
read online

Issue 2, January 2011: Biologic Therapeutics in Psoriasis
read online

Issue 1, July 2010: Randomized Controlled Trials
read online





BJD Virtual Issue Number 5, November 2012



Dermatologic Surgery Articles


For the fifth Virtual Issue, the BJD has collated ten recent articles relating to dermatologic surgery. Over the last three years the BJD has attracted the submission of high impact, good quality papers on this subject – feel free to read, cite, and share!

1 Is Mohs micrographic surgery more effective than wide local excision for treatment of dermatofibrosarcoma protuberans in reducing risk of local recurrence? A critically appraised topic
R.J. Barlow, R. Mallipeddi, N. Sheth
British Journal of Dermatology Accepted Article
  
2 Effectiveness of combined pulsed dye and Q-switched ruby laser treatment for large to giant congenital melanocytic naevi
E. Funayama, S. Sasaki, H. Furukawa, et al.
British Journal of Dermatology Volume: 167 Issue: 5 Pages: 1085-1091.
  
3

Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases. Our experience and a long-term follow-up
E. Dika, B. M. Piraccini, R. Balestri, S. Vaccari, C. Misciali, A. Patrizi and P. A. Fanti
British Journal of Dermatology Volume 167: issue 6, Pages: 1310-1314

  
4 Surgical scar remodelling after photodynamic therapy using aminolaevulinic acid or its methylester: a retrospective, blinded study of patients with field cancerization
F.H. Sakamoto, L. Izikson, Z. Tannous, et al.
British Journal of Dermatology Volume: 166 Issue: 2 Pages: 413-416.
  
5

Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study
S. van der Geer, J. Martens, J. van Roij, E. Brand, J.U. Ostertag, M.E.J.M. Verhaegh, H.A.M. Neumann and G.A.M. Krekels
British Journal of Dermatology, Volume 167, Issue 1, Pages: 110–115

 
A modified, improved, easy and fast technique for split-thickness skin grafting
M. Kneilling, H. Breuninger, W. Schippert, et al.
British Journal of Dermatology Volume: 165 Issue: 3 Pages: 581-584
  
Local anaesthetic preparation in dermatological surgery: a labour- and time-efficient approach
C. Gleeson, W. Hussain, J. Spreadborough, et al.
British Journal of Dermatology Volume: 164 Issue: 4 Pages: 888-890
  
8 Perioperative confocal microscopy of the nail matrix in the management of in situ or minimally invasive subungual melanomas
S. Debarbieux, V. Hospod, L. Depaepe, et al.
British Journal of Dermatology Volume: 167 Issue: 4 Pages: 828-836
  
9 Patient satisfaction with post-operative telephone calls after Mohs micrographic surgery: a New Zealand and U.K. experience
J. Hafiji, P. Salmon and W. Hussain
British Journal of Dermatology Volume: 167 Issue: 3 Pages: 570-574
  
10 Rapid wound healing of scalp wounds devoid of periosteum with milling of the outer table and split-thickness skin grafting
M. Mühlstädt, C. Thomé and C. Kunte
British Journal of Dermatology Volume: 167 Issue: 2 Pages: 343-347
  




BJD Virtual Issue Number 4, August 2012



Top cited Melanoma articles


For the fourth Virtual Issue, the BJD has collated the top 10 most cited melanoma research articles since 2009. Over the last three years the BJD has attracted the submission of high impact, good quality papers on this subject which includes the revised UK guidelines for the management of cutaneous melanoma.

1 Melanoma epidemic: a midsummer night's dream?
Levell N. J.; Beattie C. C.; Shuster S.; et al.
British Journal of Dermatology Volume: 161 Issue: 3 Pages: 630-634
  
2 Revised UK guidelines for the management of cutaneous melanoma 2010
Marsden J. R.; Newton-Bishop J. A.; Burrows L.; et al.
British Journal of Dermatology Volume: 163 Issue: 2 Pages: 238-256.
  
3 Systematic review of dermoscopy and digital dermoscopy/artificial intelligence for the diagnosis of melanoma
Rajpara S. M.; Botello A. P.; Townend J.; et al.
British Journal of Dermatology Volume: 161 Issue: 3 Pages: 591-604
 
Slow-growing melanoma: a dermoscopy follow-up study
Argenziano G.; Kittler H.; Ferrara G.; et al.
British Journal of Dermatology Volume: 162 Issue: 2 Pages: 267-273
  
Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis
Lee J. -H.; Choi J. -W.; Kim Y. -S.
British Journal of Dermatology Volume: 164 Issue: 4 Pages: 776-784
  
6 TRAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis
Dadzie O. E.; Yang S.; Emley A.; et al.
British Journal of Dermatology Volume: 160 Issue: 2 Pages: 368-375
  
7 Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002
Werzowa J.; Cejka D.; Fuereder T.; et al.
British Journal of Dermatology Volume: 160 Issue: 5 Pages: 955-964
  
8 Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study

British Journal of Dermatology Volume: 161 Issue: 6 Pages: 1307-1316
  
9 Sunscreens as a preventative measure in melanoma: an evidence-based approach or the precautionary principle?
Diffey B. L.
British Journal of Dermatology Volume: 161 Pages: 25-27.
  
10 AThe role of human endogenous retroviruses in melanoma
Singh S.; Kaye S.; Gore M. E.; et al
British Journal of Dermatology Volume: 161 Issue: 6 Pages: 1225-1231
  

Return to top





Top Cited Asian Publications


To mark the World Congress of Dermatology in South Korea and recognise the high quality research from Asia, the BJD has collated the highest cited articles since 2008 for the second virtual issue of 2011. The BJD strives to attract the submission of high impact, good quality papers from all over the world. The number of submissions from Asia has grown over recent years and this is reflected by the number of papers accepted for publication and in the subsequent citation of these papers.

1 Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy
C-H. Yang, W-C. Lin, C-K. Chuang, Y-C. Chang, S-T. Pang, Y-C. Lin, T-T. Kuo, J-J. Hsieh, J.W.C. Chang
British Journal of Dermatology 2008; 158: 592-596.
  
2 Plasma adiponectin and leptin levels in Japanese patients with psoriasis
H. Takahashi, H. Tsuji, I. Takahashi, Y. Hashimoto, A. Ishida-Yamamoto, H. Iizuka
British Journal of Dermatology 2008; 159: 1207-1208.
  
3 Comparison of the depth profiles of water and water-binding substances in the stratum corneum determined in vivo by Raman spectroscopy between the cheek and volar forearm skin: effects of age, seasonal changes and artificial forced hydration
M. Egawa, H. Tagami
British Journal of Dermatology 2008; 158: 251-260.
 
Psoriasis is associated with increased levels of serum leptin
Y. Wang, J. Chen, Y. Zhao, L. Geng, F. Song, H-D. Chen
British Journal of Dermatology 2008; 158: 1134-1135.
  
Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus
Y. Luo, Y. Li, Y. Su, H. Yin, N. Hu, S. Wang, Q. Lu
British Journal of Dermatology 2008; 159: 827-833.
  
6 Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas
A.K. Kivisaari, M. Kallajoki, T. Mirtti, J.A. McGrath, J.W. Bauer, F. Weber, R. Königová, D. Sawamura, K.C. Sato-Matsumura, H. Shimizu, M. Csikós, K. Sinemus, W. Beckert, V-M. Kähäri
British Journal of Dermatology 2008; 158: 778-785.
  
7 Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin
J.B. Lee, J.Y. Choi, J.S. Chun, S.J. Yun, S.C. Lee, J. Oh, H.R. Park
British Journal of Dermatology 2008; 159: 61-67.
  
8 In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption
Y. Mizukawa, Y. Yamazaki, T. Shiohara
British Journal of Dermatology 2008; 158: 1230-1238.
  
9 Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars
B. Cheng, H-W. Liu, X-B. Fu, Z-Y. Sheng, J-F. Li
British Journal of Dermatology 2008; 158: 713-720.
  
10 A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0•01%, hydroquinone 4%, tretinoin 0•05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma
R. Chan, K.C. Park, M.H. Lee, E-S. Lee, S.E. Chang, Y.H. Leow, Y-K. Tay, F. Legarda-Montinola, R-Y. Tsai, T-H. Tsai, S. Shek, N. Kerrouche, G. Thomas, V. Verallo-Rowell
British Journal of Dermatology 2008; 159: 697-703.
  
11  Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides
T. Fujimura, R. Okuyama, Y. Ito, S. Aiba
British Journal of Dermatology 2008; 158: 1256-1263.
  
12  Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis
M. Tominaga, H. Ogawa, K. Takamori
British Journal of Dermatology 2008; 158: 842-844.
  
13 Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
W.J. Lee, J.L. Lee, S.E. Chang, M.W. Lee, Y.K. Kang, J.H. Choi, K.C. Moon, J.K. Koh
British Journal of Dermatology 2009; 161: 1045-1051.
  
14 Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study
Y.L. Huang, Y.J. Chen, M.W. Lin, C.Y. Wu, P.C. Liu, T.J. Chen, Y.C. Chen, J.S. Jih, C.C. Chen, D.D. Lee, Y.T. Chang, W.J. Wang, H.N. Liu
British Journal of Dermatology 2009; 161: 854-860.
  
15 Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes
M. Kobayashi, R. Yoshiki, J. Sakabe, K. Kabashima, M. Nakamura, Y. Tokura
British Journal of Dermatology 2009; 160: 297-304.

Return to top



BJD Virtual Issue Number 2, January 2011



Biologic Therapeutics in Psoriasis


Biologic treatments in psoriasis have rapidly evolved over the past few years such that their use is now common place for most Dermatologists. It is essential that high quality research is published in order to produce guidelines for use, understand long term risks, and fully understand the health economics of such treatments when advising commissioners of health care. Over the last 2 years the BJD has published a number of papers on this subject including the health economics of use, longer term side effects and risks of treatment, and benefit of switching between biologic therapies. These have been pulled together to form this Virtual Issue.

1 Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study
R.T. Woolf, C.H. Smith, K. Robertson, J.N.W.N. Barker
British Journal of Dermatology 2010; 163: 889-892.
  
2 Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept
P.P.M. van Lümig, Lecluse, R.J.B. Driessen, P.I. Spuls, J.B. Boezeman, P.C.M. Van De Kerkhof and E.M.G.J. de Jong
British Journal of Dermatology 2010; 163: 838-846.
  
3 A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis
A. Fonia, K. Jackson, C. LeReun, D.M. Grant, J.N.W.N. Barker and C.H. Smith
British Journal of Dermatology 2010; 163: 807-816
 
Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis
R.G. Langley, B.E. Strober, Y. Gu, S.J. Rozzo, M.M. Okun
British Journal of Dermatology 2010; 162: 1349-1358.
  
The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics
R.J.B. Driessen, L.A. Bisschops, E.M.M. Adang, A.W. Evers, P.C.M. van de Kerkhof, E.M.G.J. de Jong
British Journal of Dermatology 2010; 162: 1324-1329.
  
6 Antinuclear antibodies associate with loss of response to antitumour necrosis factor-α therapy in psoriasis: a retrospective, observational study
A.E. Pink, A. Fonia, M.H. Allen, C.H. Smith, J.N.W.N. Barker
British Journal of Dermatology 2010; 162: 780-785.
  
7 Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial
M. Lebwohl, K. Papp, C. Han, B. Schenkel, N. Yeilding, Y. Wang, G.G. Krueger
British Journal of Dermatology 2010; 162: 137-146.
  
8 The relevance of biologics for the treatment of patients with psoriasis
Peter C.M. van de Kerkhof
British Journal of Dermatology 2009; 161: 1213-1214.
  
9 Etanercept and infections
J. Bertouch
British Journal of Dermatology 2009; 161: 1209-1210.
  
10 Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept
J.-P. Ortonne, A. Taïeb, A.D. Ormerod, D. Robertson, J. Foehl, R. Pedersen, C. Molta and B. Freundlich
British Journal of Dermatology 2009; 161: 1190-1195.
  
11  British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009
C.H. Smith, A.V. Anstey, J.N.W.N. Barker, A.D. Burden, R.J.G. Chalmers, D.A. Chandler, A.Y. Finlay, C.E.M. Griffiths, K. Jackson, N.J. McHugh, K.E. McKenna, N.J. Reynolds, A.D. Ormerod
British Journal of Dermatology 2009; 161: 987-1019.
  
12  Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test
E. Laffitte, J.P. Janssens, P. Roux-Lombard, A.M. Thielen, C. Barde, G. Marazza, R.G. Panizzon, J.-H. Saurat
British Journal of Dermatology 2009; 161: 797-800.
  
13 Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension
P.C.M. van de Kerkhof, S. Segaert, M. Lahfa, T.A. Luger, Z. Karolyi, A. Kaszuba, G. Leigheb, F.M. Camacho, D. Forsea, C. Zang, M.P. Boussuge, L. Paolozzi, J. Wajdula
British Journal of Dermatology 2008; 159: 1177-1185.
  
14 Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
J. Schmitt, Z. Zhang, G. Wozel, M. Meurer, W. Kirch
British Journal of Dermatology 2008; 159: 513-526.
  
15 Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials
A.K. Brimhall, L.N. King, J.C. Licciardone, H. Jacobe, A. Menter
British Journal of Dermatology 2008; 159: 274-285.
16 Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
J.-H. Saurat, G. Stingl, L. Dubertret, K. Papp, R.G. Langley, J.-P. Ortonne, K. Unnebrink, M. Kaul, A. Camez 
British Journal of Dermatology 2009; 158: 558-566.

Return to top



BJD Virtual Issue Number 1, July 2010



Randomized Controlled Trials


In a time where treatments are being prioritised according to their cost and benefit, evidence is vital; treatments of common, chronic, skin diseases can be expensive and in order to provide robust clinical evidence of new treatments, well conducted RCTs are essential. This first Virtual Issue from BJD consists of randomized controlled trials (RCTs) from the therapeutics section of the journal over the past two years.


1 Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year
B. Kütting, T. Baumeister, W. Weistenhöfer, A. Pfahlberg, W. Uter, H. Drexler
British Journal of Dermatology 2010; 162: 362-370.
  
2 Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study
Z. Apalla, E. Sotiriou, E. Chovarda, I. Lefaki, D. Devliotou-Panagiotidou, D. Ioannides
British Journal of Dermatology 2010; 162: 171-175.
  
3 A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist
M.L.A. Schuttelaar, K.M. Vermeulen, N. Drukker, P.J. Coenraads
British Journal of Dermatology 2010; 162: 162-170.
 
A cosmetic 'anti-ageing' product improves photoaged skin: a double-blind, randomized controlled trial
R.E.B. Watson, S. Ogden, L.F. Cotterell, J.J. Bowden, J.Y. Bastrilles, S.P. Long, C.E.M. Griffiths
British Journal of Dermatology 2009; 161: 419-426.
  
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies
A. Hauschild, E. Stockfleth, G. Popp, F. Borrosch, H. Brüning, R. Dominicus, H. Mensing, U. Reinhold, K. Reich, A.C.E. Moor, M. Stocker, C. Ortland, M. Brunnert, R.-M. Szeimies
British Journal of Dermatology 2009; 160: 1066-1074.
  
6 The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial
P.H. Hoeger, K-H. Lee, J. Jautova, J. Wohlrab, A. Guettner, G. Mizutani, T. Hultsch
British Journal of Dermatology 2009; 160: 415-422.
  
7 Pulsed dye laser vs. intense pulsed light for port-wine stains: a randomized side-by-side trial with blinded response evaluation
A. Faurschou, K. Togsverd-Bo, C. Zachariae, M. Hædersdal
British Journal of Dermatology 2009; 160: 359-364.
  
8 Fractionated 5-aminolaevulinic acid–photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial
K. Mosterd, M.R.T.M. Thissen, P. Nelemans, N.W.J. Kelleners-Smeets, R.L.L.T. Janssen, K.G.M.E. Broekhof, H.A.M. Neumann, P.M. Steijlen, D.I.M. Kuijpers
British Journal of Dermatology 2009; 159: 864-870.
  
9 Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study
R. Sidbury, A.F. Sullivan, R.I. Thadhani, C.A. Camargo Jr
British Journal of Dermatology 2009; 159: 245-247.
  
10 Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial
P. Gisondi, M. Del Giglio, C. Cotena, G. Girolomoni
British Journal of Dermatology 2009; 158: 1345-1349.
  
11  Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
T. Ruzicka, C.W. Lynde, G.B.E. Jemec, T. Diepgen, J. Berth-Jones, P.J. Coenraads, A. Kaszuba, R. Bissonnette, E. Varjonen, P. Holló, F. Cambazard, M. Lahfa, P. Elsner, F. Nyberg, A. Svensson, T.C. Brown, M. Harsch, J. Maares 
British Journal of Dermatology 2009; 158: 808-817.
  
12  Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
J.-H. Saurat, G. Stingl, L. Dubertret, K. Papp, R.G. Langley, J.-P. Ortonne, K. Unnebrink, M. Kaul, A. Camez 
British Journal of Dermatology 2009; 158: 558-566.
  
13 Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
D. Revicki, M.K. Willian, J.-H. Saurat, K.A. Papp, J.-P. Ortonne, C. Sexton, A. Camez 
British Journal of Dermatology 2009; 158: 549-557.
  
14 A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting
J. de Korte, P.G.M. van der Valk, M.A.G. Sprangers, R.J. Damstra, A.C.M. Kunkeler, R.L.P. Lijnen, A.P. Oranje, M.A. de Rie, F.B. de Waard-van der Spek, C.W. Hol, P.C.M. van de Kerkhof 
British Journal of Dermatology 2009; 158: 375-381.
  
15 Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial
I. Flytström, B. Stenberg, Å. Svensson, I-M. Bergbrant 
British Journal of Dermatology 2009; 158: 116-121.

Return to top


www.brjdermatol.org

SEARCH

SEARCH BY CITATION